Home›Companies›Auxergen

Auxergen, Inc.

Updated Oct 29, 2026·Latest SEC filing May 5, 2023·Suggest an edit

About Auxergen

Auxergen is a private company based in Balitmore, Maryland. It has reported $535,000 raised in one offering on Form D since April 2021. Its chief executive is Gregory Contreras.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 5, 2021Apr 16, 2021amended May 5, 2023$535,000of $1.0M target11$48,636EquityRule 506(b)Form D/A ↗2 earlier filings

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Auxergen's Form D filed May 5, 2023.

TY
Ting Yu-Yeh
Executive officer and director
GC
Gregory Contreras
Chief Executive Officer and director

Sources

  1. SECAuxergen, Inc. Form D/A, filed Aug 24, 2022
  2. SECAuxergen, Inc. Form D, filed Apr 16, 2021
  3. SECAuxergen, Inc. filing history